Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2024

Feb 26, 2024

34129_dirs_2024-02-26_acaadc83-f106-47f0-818d-7c4af21cb821.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2024-02-22

Reporting Person: Peters Jeffrey Stuart (Senior VP and General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-02-22 Common Stock M 26250 Acquired 35145 Direct
2024-02-22 Common Stock F 10126 $17.11 Disposed 25019 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-02-22 Restricted Stock Unit $0 M 26250 Disposed Common Stock (26250) Direct

Footnotes

F1: On February 22, 2022 the reporting person was granted 35,000 restricted stock units, 25% of which vested on February 22, 2023 and 75% on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis.